Cargando…
Refining eligibility criteria for amyotrophic lateral sclerosis clinical trials
OBJECTIVE: To assess the effect of eligibility criteria on exclusion rates, generalizability, and outcome heterogeneity in amyotrophic lateral sclerosis (ALS) clinical trials and to assess the value of a risk-based inclusion criterion. METHODS: A literature search was performed to summarize the elig...
Autores principales: | van Eijk, Ruben P.A., Westeneng, Henk-Jan, Nikolakopoulos, Stavros, Verhagen, Iris E., van Es, Michael A., Eijkemans, Marinus J.C., van den Berg, Leonard H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6369899/ https://www.ncbi.nlm.nih.gov/pubmed/30626653 http://dx.doi.org/10.1212/WNL.0000000000006855 |
Ejemplares similares
-
Comparing methods to combine functional loss and mortality in clinical trials for amyotrophic lateral sclerosis
por: van Eijk, Ruben PA, et al.
Publicado: (2018) -
Monitoring disease progression with plasma creatinine in amyotrophic lateral sclerosis clinical trials
por: van Eijk, Ruben P A, et al.
Publicado: (2018) -
Innovating Clinical Trials for Amyotrophic Lateral Sclerosis: Challenging the Established Order
por: van Eijk, Ruben P.A., et al.
Publicado: (2021) -
Critical design considerations for time-to-event endpoints in amyotrophic lateral sclerosis clinical trials
por: van Eijk, Ruben P A, et al.
Publicado: (2019) -
The Distinct Traits of the UNC13A Polymorphism in Amyotrophic Lateral Sclerosis
por: Tan, Harold H. G., et al.
Publicado: (2020)